ClinVar Miner

Submissions for variant NM_017946.4(FKBP14):c.357T>G (p.Ile119Met)

gnomAD frequency: 0.00009  dbSNP: rs202182643
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000490237 SCV000576926 uncertain significance not provided 2018-09-13 criteria provided, single submitter clinical testing The I119M variant in the FKBP14 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The I119M variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The I119M variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. However, this substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret I119M as a variant of uncertain significance.
Invitae RCV000698654 SCV000827334 uncertain significance Ehlers-Danlos syndrome, kyphoscoliotic and deafness type 2022-10-13 criteria provided, single submitter clinical testing This sequence change replaces isoleucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 119 of the FKBP14 protein (p.Ile119Met). This variant is present in population databases (rs202182643, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with FKBP14-related conditions. ClinVar contains an entry for this variant (Variation ID: 426476). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Knight Diagnostic Laboratories, Oregon Health and Sciences University RCV001270094 SCV001448911 uncertain significance Hypotonia 2019-05-20 criteria provided, single submitter clinical testing
Ambry Genetics RCV002455946 SCV002613596 uncertain significance Cardiovascular phenotype 2021-11-09 criteria provided, single submitter clinical testing The p.I119M variant (also known as c.357T>G), located in coding exon 3 of the FKBP14 gene, results from a T to G substitution at nucleotide position 357. The isoleucine at codon 119 is replaced by methionine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Mayo Clinic Laboratories, Mayo Clinic RCV000490237 SCV004224004 uncertain significance not provided 2022-10-11 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.